This was the stock's second consecutive day of gains.

The stock's rise snapped a four-day losing streak.

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like PTC (NASDAQ:PTC). While profit isn't the sole metric that should be ...

In an interview with CRN, new PTC Chief Partner Officer Kimberly King, formerly of Hitachi Vantara, talks about her plans to simplify the industrial software vendor’s partner program, make services ...

PTC Therapeutics’ stock narrative has shifted as analysts raise their consensus price target from $77.93 to $80.50. This reflects heightened optimism around the company’s outlook. This change comes in ...

PTC Therapeutics has long been trying to workshop its vatiquinone into a marketable treatment for Friedreich's ataxia (FA) after a phase 3 fail in 2023. Despite its efforts, the FDA has snubbed the ...

Novartis is paying $1 billion upfront for global rights to PTC Therapeutics’ midphase Huntington's disease program, helping the biotech bounce quickly back from disappointing data on another program.

The organization says the footage illustrates why consumers should be able to choose whether they want to pay for this content By Hilary Lewis Deputy Editor, East Coast The Parents Television Council ...

An update from PTC India Limited ( ($IN:PTC) ) is now available. PTC India Limited has disclosed that its Registrar and Share Transfer Agent, MCS ...

Thousands of C-suite executives, researchers, entrepreneurs and government leaders convene each year to help plan what’s next for satellites, undersea cables and much of the hardware that makes the ...

An announcement from PTC India Financial Services Limited ( ($IN:PFS) ) is now available. PTC India Financial Services Limited has announced that ...

OAKDALE, Pa. — A local technical college and pillar for students and employees in the region is closing its doors abruptly amid investigations and growing questions about what went so wrong, so fast.